Yantai Dongcheng Pharmaceutical Co Ltd (002675) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.014x

Based on the latest financial reports, Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥74.53 Million ≈ $10.91 Million USD) by net assets (CN¥5.45 Billion ≈ $796.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Yantai Dongcheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Yantai Dongcheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002675 current and long-term liabilities for a breakdown of total debt and financial obligations.

Yantai Dongcheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yantai Dongcheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lonking Holdings Limited F:C9IB	0.042x
Mitra Keluarga Karyasehat Tbk PT JK:MIKA	0.041x
Herbalife Nutrition Ltd NYSE:HLF	-0.193x
ELECTROLUX B ADR/2 SK 5 F:ELXA	0.528x
Pexa Group Ltd AU:PXA	0.053x
BW Energy Ltd OL:BWE	0.798x
Intellia Therapeutics Inc NASDAQ:NTLA	-0.103x
BlackRock Capital Allocation Trust NYSE:BCAT	N/A

Annual Cash Flow Conversion Efficiency for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see 002675 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥5.37 Billion ≈ $786.01 Million	CN¥287.15 Million ≈ $42.02 Million	0.053x	+4.15%
2023-12-31	CN¥5.40 Billion ≈ $789.55 Million	CN¥276.94 Million ≈ $40.53 Million	0.051x	-72.79%
2022-12-31	CN¥5.28 Billion ≈ $772.97 Million	CN¥996.54 Million ≈ $145.82 Million	0.189x	+0.44%
2021-12-31	CN¥5.02 Billion ≈ $735.14 Million	CN¥943.58 Million ≈ $138.08 Million	0.188x	+62.89%
2020-12-31	CN¥4.97 Billion ≈ $726.63 Million	CN¥572.58 Million ≈ $83.79 Million	0.115x	-20.87%
2019-12-31	CN¥4.78 Billion ≈ $699.31 Million	CN¥696.38 Million ≈ $101.90 Million	0.146x	+36.26%
2018-12-31	CN¥4.61 Billion ≈ $674.68 Million	CN¥493.06 Million ≈ $72.15 Million	0.107x	+68.33%
2017-12-31	CN¥3.29 Billion ≈ $481.25 Million	CN¥208.94 Million ≈ $30.57 Million	0.064x	-0.18%
2016-12-31	CN¥3.08 Billion ≈ $451.28 Million	CN¥196.28 Million ≈ $28.72 Million	0.064x	+113.39%
2015-12-31	CN¥2.24 Billion ≈ $327.19 Million	CN¥66.69 Million ≈ $9.76 Million	0.030x	-32.08%
2014-12-31	CN¥1.18 Billion ≈ $173.30 Million	CN¥52.00 Million ≈ $7.61 Million	0.044x	+334.72%
2013-12-31	CN¥1.10 Billion ≈ $161.16 Million	CN¥-20.60 Million ≈ $-3.01 Million	-0.019x	-142.66%
2012-12-31	CN¥1.02 Billion ≈ $148.60 Million	CN¥44.53 Million ≈ $6.52 Million	0.044x	-90.38%
2011-12-31	CN¥304.42 Million ≈ $44.55 Million	CN¥138.83 Million ≈ $20.31 Million	0.456x	+52.81%
2010-12-31	CN¥191.06 Million ≈ $27.96 Million	CN¥57.02 Million ≈ $8.34 Million	0.298x	+257.54%
2009-12-31	CN¥140.43 Million ≈ $20.55 Million	CN¥-26.60 Million ≈ $-3.89 Million	-0.189x	-136.16%
2008-12-31	CN¥79.34 Million ≈ $11.61 Million	CN¥41.57 Million ≈ $6.08 Million	0.524x	--

About Yantai Dongcheng Pharmaceutical Co Ltd

SHE:002675 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.57 Billion

CN¥10.71 Billion CNY

Market Cap Rank

#7207 Global

#1701 in China

Share Price

CN¥12.99

Change (1 day)

-2.48%

52-Week Range

CN¥12.24 - CN¥18.29

All Time High

CN¥27.09